Core Scientific (NASDAQ:CORZ - Get Free Report) is set to release its earnings data after the market closes on Wednesday, November 6th. Analysts expect Core Scientific to post earnings of ($0.11) per share for the quarter.
Core Scientific (NASDAQ:CORZ - Get Free Report) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($4.51) EPS for the quarter, missing the consensus estimate of ($0.04) by ($4.47). The firm had revenue of $141.10 million during the quarter, compared to the consensus estimate of $128.58 million. The firm's revenue for the quarter was up 11.2% on a year-over-year basis. On average, analysts expect Core Scientific to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Core Scientific Stock Down 3.6 %
Shares of NASDAQ CORZ traded down $0.49 during midday trading on Thursday, hitting $13.29. 10,125,957 shares of the company's stock were exchanged, compared to its average volume of 8,713,353. Core Scientific has a 12-month low of $2.61 and a 12-month high of $14.64. The business's fifty day moving average price is $11.80 and its two-hundred day moving average price is $8.88.
Insider Buying and Selling
In other news, CFO Denise Marie Brucia Sterling sold 8,752 shares of the stock in a transaction on Friday, August 16th. The stock was sold at an average price of $9.41, for a total value of $82,356.32. Following the sale, the chief financial officer now directly owns 122,217 shares of the company's stock, valued at approximately $1,150,061.97. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other Core Scientific news, Director Jarrod M. Patten acquired 4,000 shares of the company's stock in a transaction that occurred on Wednesday, August 28th. The shares were bought at an average cost of $9.70 per share, with a total value of $38,800.00. Following the completion of the transaction, the director now directly owns 279,239 shares of the company's stock, valued at approximately $2,708,618.30. This represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Denise Marie Brucia Sterling sold 8,752 shares of the stock in a transaction on Friday, August 16th. The shares were sold at an average price of $9.41, for a total value of $82,356.32. Following the sale, the chief financial officer now directly owns 122,217 shares in the company, valued at $1,150,061.97. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have bought a total of 12,761 shares of company stock valued at $127,080 over the last ninety days. Company insiders own 32.00% of the company's stock.
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on CORZ shares. Compass Point boosted their target price on Core Scientific from $18.00 to $20.00 and gave the stock a "buy" rating in a research report on Wednesday, October 23rd. B. Riley boosted their target price on Core Scientific from $13.00 to $14.00 and gave the stock a "buy" rating in a research report on Friday, October 11th. Cantor Fitzgerald restated an "overweight" rating and issued a $20.00 target price on shares of Core Scientific in a research report on Thursday, October 3rd. Needham & Company LLC boosted their target price on Core Scientific from $16.00 to $17.00 and gave the stock a "buy" rating in a research report on Wednesday, October 23rd. Finally, Macquarie assumed coverage on Core Scientific in a research report on Wednesday, September 25th. They issued an "outperform" rating and a $16.00 target price for the company. Twelve investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $16.71.
View Our Latest Research Report on Core Scientific
Core Scientific Company Profile
(
Get Free Report)
Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.
Read More
Before you consider Core Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Scientific wasn't on the list.
While Core Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.